Atrys Health, S.A. (BME:ATRY)

Market Cap	248.87M
Revenue (ttm)	226.24M
Net Income (ttm)	-24.59M
Shares Out	75.87M
EPS (ttm)	-0.32
PE Ratio	n/a
Forward PE	218.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,406
Average Volume	135,482
Open	3.390
Previous Close	3.370
Day's Range	3.370 - 3.410
52-Week Range	2.480 - 3.670
Beta	0.64
RSI	61.62
Earnings Date	Dec 23, 2025

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,045
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ATRY

Financial Performance

In 2024, Atrys Health's revenue was 218.10 million, an increase of 5.82% compared to the previous year's 206.10 million. Losses were -31.77 million, -30.30% less than in 2023.